Condylomata Acuminata: all 116 studies
Page 1 of 2. Open to participants first (11), then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of Oral Ivermectin for Genital WartsNot yet recruitingNCT07913321Not applicable
- Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa GelRecruitingNCT07698886Phase 2
- Comparison Between Efficacy of Topical 25%Podophyllin and Cryotherapy on Genital WartsNot yet recruitingNCT06809777Phase 2
- To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 YearsRecruitingNCT06756269Phase 2
- Effector and Memory Immune Responses to HPV Vaccination in Vietnamese Women Post Virus ExposureNot yet recruitingNCT06681636Phase 2
- Effectivity of Protein Purified Derivative Treatment for Anogenital Warts in HIV PatientNot yet recruitingNCT06587542Phase 2/3
- Peginterferon α-2b Combined CO2 Laser in Condylomata AcuminataNot yet recruitingNCT06430190Not applicable
- Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV VaccineRecruitingNCT05371353
- Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 YearsRecruitingNCT05027776Phase 3
- Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 YearsRecruitingNCT04895020Phase 3
- Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy FemalesRecruitingNCT04422366Phase 3
- Intralesional HPV Vaccine for CondylomataCompletedNCT05087849Phase 1/2Results posted
- Efficacy, Immunogenicity, and Safety Study of V503 (9-valent Human Papillomavirus [9vHPV] Vaccine) in Japanese Males (V503-064)CompletedNCT04635423Phase 3Results posted
- A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital WartsCompletedNCT03981822Phase 2Results posted
- Safety and Immunogenicity Study of V503 (GARDASIL™9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females and Males in Vietnam (V503-017)CompletedNCT03546842Phase 3Results posted
- Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004)CompletedNCT03158220Phase 3Results posted
- Effectiveness Study of Human Papilloma Virus (HPV) Vaccines to Prevent Recurrence of Genital WartsCompletedNCT02750202Phase 3Results posted
- HPV Vaccination: An Investigation of Physician Reminders and Recommendation ScriptsCompletedNCT02551887Not applicableResults posted
- Efficacy and Tolerability of Topical LFX453 for External Genital WartsCompletedNCT02482428Phase 2Results posted
- Topical NVN1000 for the Treatment of External Genital and Perianal WartsCompletedNCT02462187Phase 2Results posted
- Treatment of External Genital Warts With Cryotherapy and Sinecatechins 15% OintmentCompletedNCT02147353Not applicableResults posted
- Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003)CompletedNCT01651949Phase 3Results posted
- Human Papillomavirus (HPV) Types Present in External Genital Warts (EGW) in the Argentinean PopulationCompletedNCT01598779Results posted
- GARDASIL™ Study in Healthy Females Between 9 and 26 Years of Age in Sub-Saharan Africa (V501-046)CompletedNCT01245764Phase 3Results posted
- Typing of Human Papilloma Virus (HPV) From Female Genital WartsCompletedNCT01192282Results posted
- A Study of V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ (V503-006)CompletedNCT01047345Phase 3Results posted
- Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the HandsCompletedNCT00973856Not applicableResults posted
- Alternate Dosing Schedules Study for HPV VaccineCompletedNCT00862810Phase 4Results posted
- Broad Spectrum HPV Vaccine Dose Escalation Study (V502-002)CompletedNCT00851643Phase 1Results posted
- Phase 3 Study of Imiquimod Creams in the Treatment of External Genital WartsCompletedNCT00735462Phase 3Results posted
- Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital WartsCompletedNCT00674739Phase 3Results posted
- Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)CompletedNCT00543543Phase 3Results posted
- Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil) (V501-015)CompletedNCT00092534Phase 3Results posted
- Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED)CompletedNCT00092521Phase 3Results posted
- Study of an Investigational Vaccine in Pre-Adolescents and Adolescents (Gardasil)(V501-016)CompletedNCT00092495Phase 3Results posted
- An Investigational Study of Gardasil™ (qHPV Vaccine) in Reducing the Incidence of Anogenital Warts in Young Men (V501-020)CompletedNCT00090285Phase 3Results posted
- Long Term Follow-up of HPV Vaccine in HIV (CTN 236)CompletedNCT06915779
- A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese MalesActive, not recruitingNCT06866574Phase 3
- Impact of HPV Vaccination Against Cervical Lesions and Genital Warts in Colombia. an Ecological AssessmentCompletedNCT06700941
- A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese MalesActive, not recruitingNCT06465914Phase 3
- A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 YearsActive, not recruitingNCT06454175Phase 1
- Cavitronic Ultrasonic Surgical Aspiration (CUSA) Women's Health StudyCompletedNCT06297187
- The Effect of Oral Nanocurcumin as an Adjuvant Therapy for Anogenital Warts: Evaluation of Clinical Improvement, NFĸB, IFN-γ, and FOXP3+TReg From Lesions TissueCompletedNCT06281353Phase 2/3
- Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young WomenActive, not recruitingNCT06197802
- Human Papilloma Virus Genotypes and Treatment Outcomes of Intralesional Immunotherapy of Anogenital WartsStatus unknownNCT05761002Not applicable
- A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV VaccineCompletedNCT05694728Phase 2
- A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV VaccineCompletedNCT05680454Phase 1
- A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in ChinaActive, not recruitingNCT05662020Phase 3
- Topical Ethanol Extract (Piper Crocatum) for Anogenital WartsStatus unknownNCT05622916Not applicable
- A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy FemalesTerminatedNCT05584332Phase 3
- Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9Status unknownNCT05580341Phase 3
- Evaluate the Safety and Immunogenicity of a 9-valent HPV Vaccine in Chinese Healthy Male Aged 9-45 Year-oldCompletedNCT05518201Phase 1
- Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy FemalesCompletedNCT05372016Phase 3
- Immunogenicity and Safety of V503 in Chinese Males 9 Through 19 Years Old (V503-053)Active, not recruitingNCT05314023Phase 3
- Study of the Efficacy and Safety of the Drug Ingaron (Interferon-gamma) in the Treatment of Anogenital WartsCompletedNCT05156541Phase 3
- Interleukin 4 and Interferon Gamma Predictors of Human Papillomavirus Immunotherapy in WartsCompletedNCT05100043
- An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years OldActive, not recruitingNCT05056402Phase 3
- Education, Immigration and HPV Vaccination: an Informational Randomized TrialStatus unknownNCT04905030Not applicable
- Genital Wart and Sexuality in AdolescenceCompletedNCT04796090
- Immunogenicity of a Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58)Vaccine(E.Coli) Versus Gardasil®9 in Healthy Females 18-26 Years of AgeCompletedNCT04782895Phase 3
- Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)Active, not recruitingNCT04537156Phase 3
- Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy FemalesCompletedNCT04425291Phase 3
- Safety and Efficacy of Laser Therapy in GynaecologyStatus unknownNCT04073082
- Conventional Photodynamic Therapy vs. Painless Photodynamic Therapy for Small Genital WartsStatus unknownNCT03948321Not applicable
- Immunogenicity Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)CompletedNCT03935204Phase 2
- Betaglucin 0.2% Versus Imiquimod 5% in Treatment of Ano-genital Warts: Combined Results From Triple Blind Controlled StudyStatus unknownNCT03901690Phase 3
- A Study of Safety and Primary Immunogenicity of 9-valent HPV Recombinant VaccineCompletedNCT03900572Phase 1
- Efficacy of Intralesional MMR Vaccine,Intralesional Candidal Antigen&Topical Podophyllin in Treatment of Genital WartsStatus unknownNCT03853785Phase 3
- Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)CompletedNCT03813940Phase 1
- Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy FemalesCompletedNCT03676101Phase 1
- Cantharone for the Treatment of Perenial WartsCompletedNCT03625960Phase 4
- Efficacy of Quadrivalent HPV Vaccine to Prevent Relapses of Genital Warts After Initial Therapeutic ResponseStatus unknownNCT03296397Phase 3
- Adjuvant Anal Imiquimod Therapy in Anal HPV-lesions: AdAM-trialStatus unknownNCT03289260Phase 3
- A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of External Genital WartsTerminatedNCT03158974Phase 2
- Safety and Efficacy of Immune Therapy for CondylomaStatus unknownNCT03158480Not applicable
- Comparison Between Tuberculin Vaccine and Cryotherapy in Genital Wart PatientsStatus unknownNCT03153566Phase 3
- Pharmacodynamics, Safety and Efficacy of Topical Omiganan in Patients With External Genital WartsCompletedNCT02849262Phase 2
- A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma PatientsCompletedNCT02724254Phase 2
- Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent VaccineActive, not recruitingNCT02710851Phase 2
- Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021)Active, not recruitingNCT02653118
- HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3CompletedNCT02558803Not applicable
- Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV)CompletedNCT02535104Phase 1/2
- Carbon Dioxide Laser vs. Electrocoagulation for the Therapy of CondylomaCompletedNCT02520986Not applicable
- Safety and Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent VaccineCompletedNCT02405520Phase 1
- Safety and Efficacy of Repeat Use of Picato® 0.05% in the Treatment of Anogenital WartsCompletedNCT02377999Phase 2
- Alternate Dosing Schedules Study for HPV Vaccine (ADS)CompletedNCT02280642
- Evaluation of Long Term Immunity Following HPV VaccinationCompletedNCT02276521
- The Epidemiologic Study of Human Papillomavirus Infection and Related DiseasesCompletedNCT02188004
- Safety Study of Multikine in the Treatment of Perianal WartsTerminatedNCT02115919Phase 1
- A Trial of the Efficacy and Safety of Topical Nitric Oxide in Patients With Anogenital WartsCompletedNCT02015260Phase 2
- Safety and Efficacy Double Blind Vehicle Controlled Study of 15% AS101 Gel to Treat External Genital WartsStatus unknownNCT01943630Phase 2
- Efficacy and Safety Profiles of SR-T100 Gel on External Genital Warts/Condyloma Acuminate(EGWs)CompletedNCT01796821Phase 2
- SR-T100 Gel Efficacy & Safety Study for Vulva Pre-cancerous Lesions & Cutaneous CondylomaCompletedNCT01676792Early Phase 1
- Recurrent and Nonrecurrent Condyloma TreatmentTerminatedNCT01639638Phase 2/3
- Effectiveness Study of Gardasil on CondylomaCompletedNCT01553994
- Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital WartsCompletedNCT01532102Phase 1/2
- The Psychosocial and Economic Burden of Genital WartsCompletedNCT01520194
- Systemic Exposure of Catechins From Veregen 15% Ointment in Patients With External Anogenital Warts and From Oral Intake of Green Tea Beverage in Healthy VolunteersCompletedNCT01490008Phase 1
- Epidemiology, Costs and Psychosocial Consequences of Genital Warts in Valparaiso, ChileStatus unknownNCT01483794
- A RTC to Examine the Effectiveness of 400 mg of Oral Zinc Gluconate as Adjunctive Therapy for Ano-genital WartsTerminatedNCT01468636Phase 4